Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1), programmed cell
death ligand-1 (PD-L1), and others have shown potent clinical efficacy and have …

The COVID-19 pandemic is challenging modern radiation oncology. At University Hospitals,
we have a mandate to offer high-end treatments to all cancer patients. However, in times of …

As the global COVID-19 pandemic escalates there is a need within radiation oncology to
work to support our patients in the best way possible. Measures are required to reduce …

Background The COVID-19 pandemic has caused radiotherapy resource pressures and led
to increased risks for lung cancer patients and healthcare staff. An international group of …

Stereotactic ablative radiotherapy (SABR) is a standard-of-care for medically-inoperable-
early-stage non-small cell lung cancer (NSCLC). One third of patients progress and …

Importance Evidence is lacking from randomized clinical trials to guide the optimal approach
for stereotactic ablative body radiotherapy (SABR) in patients with pulmonary …

Importance Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but
can cause toxic effects, including life-threatening damage to central structures …

Purpose Stereotactic body radiation therapy for early stage non-small cell lung cancer is a
standard of care for medically inoperable patients. Our aim was to compare Common …

BACKGROUND We previously demonstrated the safety of stereotactic body radiotherapy
followed by pembrolizumab (SBRT+ P) in patients with advanced solid tumors. This phase I …

Coronavirus disease 2019 (COVID-19) has had a devastating impact around the world. With
high rates of transmission and no curative therapies or vaccine yet available, the current …